Skip Navigation

Quantifying Optimal Relugolix Duration with Radiation in High Risk Prostate Cancer QURE-PC

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT06129851

Study #:
STUDY00150674

Start Date:
Nov 12, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06129851

View Complete Trial Details & Eligibility at ClinicalTrials.gov